Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor site release rather than any change to the clinical trial information.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded the term 'Gastrointestinal stromal tumor' to the page content. Added a Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check90 days agoChange DetectedMinor site revision from v3.4.1 to v3.4.2 with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.